Caesar Anderson
Undersea and Hyperbaric Medicine · San Diego, CANPI 1104071489
Payments from drug & device makers
What this record shows
7 manufacturers reported payments, led by Integra Lifesciences Corporation at 57.2% of the total.
Across 10 payments — averaging $103.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$591
- Kerecis Limited$147
- TEI Medical Inc.$123
- Biotissue Holdings Inc.$117
- Smith+Nephew$29
- Medtronic$13
- plus $12 from 1 others
What the payments were for
- Food & beverage$57356%
- Other$45944%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 4 | $591 |
| Kerecis Limited | 1 | $147 |
| TEI Medical Inc. | 1 | $123 |
| Biotissue Holdings Inc. | 1 | $117 |
| Smith+Nephew | 1 | $29 |
| Medtronic | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DURAGEN$459
- AMNIOEXCEL$254
- Kerecis Omega3 Wound$147
- Kerecis Omega3 Surgibind$147
- Kerecis Omega3 GraftGuide$147
- Kerecis Omega3 SurgiClose$147
- BILAYER WOUND MATRIX (BWM)$132
- INTEGRA WOUND MATRIX (IWM)$132
- IDRT$132
- FLOWABLE$132
- PRIMATRIX$123
- TCC-EZ$123
- Prokera$117
- AmnioGraft$117
How this compares
Too few undersea and hyperbaric medicine providers in Californiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 173 | $1,131 |
| Ciprofloxacin Hcl | 13 | $232 |
| Triamcinolone Acetonide | 43 | $165 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 40 | $137 |
| Clotrimazole | 11 | $118 |
| Tramadol Hcl | 42 | $99 |
| Clindamycin Hcl | 11 | $58 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in San Diego
- William ToppenSan Diego$239
- Kenneth KellySan Diego$82
- Latisha Smith-ChaseRedding$5K
- Yoshinobu MifuneMurrieta$2K
- John GambolPlacentia$1K
- Sara SaltzsteinCamp Pendleton$1K
- Sandra HayesCoronado$764
- John MillingtonThousand Oaks$592
- John DeaconSanta Barbara$185
- Gary WillardCarlsbad$172
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.